GMRE Insider Buys 30,894 Shares at ~$6.85 by CEO Decker

Global Medical REIT Inc. (GMRE) director and CEO Mark O. Decker Jr. reported purchases of common stock on 08/15/2025: 13,871 shares at $6.84 (direct), and 17,023 shares at $6.87 (indirect via spouse).

Rhea-AI Filing Summary

Global Medical REIT Inc. (GMRE) director and CEO Mark O. Decker Jr. reported purchases of common stock on 08/15/2025: 13,871 shares at $6.84 (direct), and 17,023 shares at $6.87 (indirect via spouse). After these transactions he beneficially owned 173,871 shares directly and 190,894 shares indirectly.

Positive

• Insider purchases recorded: CEO/director acquired 13,871 shares and spouse-acquired 17,023 shares on 08/15/2025.
• Increased beneficial ownership: Direct holdings rose to 173,871 shares and indirect holdings to 190,894.

Negative

• None.

Insights

Financial Analyst

TL;DR: CEO bought a modest number of shares at ~$6.85, increasing both direct and indirect holdings.

Mark Decker Jr. reported two purchases totaling 30,894 shares on 08/15/2025 at prices of $6.84 and $6.87. The filings show his direct beneficial ownership rose to 173,871 shares and indirect ownership (by spouse) to 190,894. For investors, insider purchases can signal alignment with shareholder value, but the filing contains no commentary on intent or materiality relative to outstanding shares.

Corporate Governance Expert

TL;DR: Transactions are routine insider purchases reported under Section 16; filing appears complete and properly signed.

The Form 4 lists purchase codes and resulting beneficial ownership and is signed by an attorney-in-fact on 08/18/2025. It identifies Decker as both director and CEO. The filing does not disclose any 10b5-1 plan notation. No amendments or other governance actions are shown.

Insider Trade Summary

Net Buyer: 30,894 shares

Net Buy 2 txns

Insider Decker Mark Okey Jr

Role CEO and President

Bought 30,894 shs ($212K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	13,871	$6.84	$95K
Purchase	Common Stock	17,023	$6.87	$117K

Holdings After Transaction: Common Stock — 173,871 shares (Direct); Common Stock — 190,894 shares (Indirect, By Spouse)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did GMRE insider Mark O. Decker Jr. report on Form 4?

The Form 4 reports two purchases on 08/15/2025: 13,871 shares at $6.84 (direct) and 17,023 shares at $6.87 (indirect via spouse).

How many GMRE shares does Mark O. Decker Jr. beneficially own after these transactions?

After the reported transactions he beneficially owned 173,871 shares directly and 190,894 shares indirectly.

When were the Form 4 transactions for GMRE filed and who signed the form?

The earliest transaction date is 08/15/2025 and the Form 4 is signed by Jamie Barber, as Attorney-in-Fact on 08/18/2025.

Did the Form 4 indicate the purchases were part of a 10b5-1 trading plan?

The filing does not indicate that these transactions were made pursuant to a 10b5-1 plan; no plan box is checked in the provided content.

What prices were paid for the GMRE shares reported on Form 4?

The reported prices were $6.84 for 13,871 shares and $6.87 for 17,023 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Decker Mark Okey Jr

(Last) (First) (Middle)

7373 WISCONSIN AVENUE, SUITE 800

(Street)

BETHESDA MD 20814

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Global Medical REIT Inc. [ GMRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		P		13,871	A	$6.84	173,871	D
Common Stock	08/15/2025		P		17,023	A	$6.87	190,894	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jamie Barber, as Attorney-in-Fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.